Effect of Diesel Exhaust Particulate Exposures on Endothelial Function in Humans
Effect of Diesel Exhaust Particulate Exposures on Endothelial Function in Humans - the Role of Oxidative Stress
調査の概要
詳細な説明
OBJECTIVES Evidence of the cardiovascular health effects of both acute and chronic exposure to ambient fine particulate matter (PM) has continued to accumulate in epidemiologic and experimental studies, without a demonstrated coherent pathophysiologic explanation. At the same time, the role of endothelial homeostasis in the development and triggering of cardiovascular disease has become more clear and compelling. Importantly, oxidative stress has emerged as a potential link between these two developments: Oxidative stress is known to play a role in endothelial dysfunction and is exerted by components of PM, especially of PM from combustion products. Based on this we propose an overall hypothesis: Inhalation of combustion-derived particles impact cardiovascular health by impairing endothelial function, through mechanisms mediated by increased oxidative stress.
Diesel exhaust particulate (DEP), an important contributor to ambient fine PM, has been demonstrated to exert oxidative stress in experimental systems. We propose a series of experiments to explore whether human exposure to DEP results in alteration of endothelial homeostasis and evidence of oxidative stress, and whether an antioxidant regimen can blunt the effects on endothelial function.
The objectives of this proposed research are to address the following specific hypotheses:
- Human exposure to inhaled DEP (at concentrations approximating 0, 100, 200 μg PM2.5/m3 [PM less than 2.5 microns in aerodynamic diameter]) results in concentration-related alteration of endothelial homeostasis, as reflected in ultrasonographic measurement of the brachial artery, plasma markers of endothelial homeostasis (endothelin-1, ICAM-1 [intercellular adhesion molecule-1], e-selectin, nitric oxide metabolites nitrate [NO3-] and nitrite [NO2-], IL-6, and TNF-α), and markers of thrombosis associated with endothelial activation or injury (plasminogen activator inhibitor-1 [PAI-1], Von Willebrand's factor [VWF], and D-dimer).
- Human exposure to inhaled DEP at 200 µg PM2.5/m3 results in evidence of systemic oxidative stress as assessed by markers in plasma and urine (isoprostane F-2α).
- Reduction in oxidant stress by ascorbate and N-acetylcysteine supplementation blunts the effect of inhaled DEP on endothelial function, as determined by ultrasonographic assessment of the brachial artery, plasma markers of endothelial homeostasis, or markers of thrombosis associated with endothelial activation.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Washington
-
Seattle、Washington、アメリカ、98105
- Northlake Laboratory
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Healthy adults aged 18-49.
Exclusion Criteria:
- Nonsmokers, no history of hypertension, asthma, diabetes, hypercholesterolemia, or other chronic conditions requiring ongoing medical care. No recent history of antioxidant, vitamin/mineral/botanical, or fatty acid supplementation beyond a daily multi-vitamin.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:クロスオーバー割り当て
- マスキング:4倍
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Diesel Exhaust
|
NAC: 600mg twice daily for the day prior to exposure and 1x pre-exposure Ascorbate: 500mg twice daily for 7 days prior to exposure
matched appearance to acetylcysteine and ascorbate intervention
|
|
偽コンパレータ:Filtered Air
|
NAC: 600mg twice daily for the day prior to exposure and 1x pre-exposure Ascorbate: 500mg twice daily for 7 days prior to exposure
matched appearance to acetylcysteine and ascorbate intervention
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Brachial artery caliber
時間枠:Pre-exposure, immediate post-exposure
|
Pre-exposure, immediate post-exposure
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
Brachial Artery Flow-Mediated Dilation
時間枠:Post-Exposure
|
Post-Exposure
|
|
Plasma Endothelin-1
時間枠:Post-exposure (adjusted for pre-exposure level)
|
Post-exposure (adjusted for pre-exposure level)
|
|
Serum IL-6
時間枠:Post-exposure (adjusted for pre-exposure level)
|
Post-exposure (adjusted for pre-exposure level)
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Joel D Kaufman, M.D., MPH、University of Washington
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
N-acetylcysteine, ascorbateの臨床試験
-
Radboud University Medical CenterHavenziekenhuis完了
-
Laval UniversityCanadian Institutes of Health Research (CIHR)募集
-
University of UlsterFederico II University募集
-
Nottingham University Hospitals NHS TrustKing's College Hospital NHS Trust; The Leeds Teaching Hospitals NHS Trust; Manchester University... と他の協力者完了気道疾患 | 肺疾患 | 嚢胞性線維症 | 遺伝病 | 消化器系疾患 | 膵臓の病気イギリス
-
University Hospital, Bordeaux終了しました
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin完了
-
Second Affiliated Hospital, School of Medicine,...Beijing Chao Yang Hospital; Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical... と他の協力者まだ募集していません